U.S. Consumer Durables Stock News

Princeton Bancorp (BPRN) posted a net profit margin of 23.2%, jumping from 15.3% a year prior, while annual earnings soared 72.5%. This marks a sharp turnaround after five years of declines. Earnings growth is forecast at an impressive 28.1% per year over the next three years, outpacing the broader US market. However, revenue is expected to grow more slowly at 4.7% per year compared to the US market’s 10.3%. Investors are weighing the improving profitability and strong growth outlook against...

Wondering whether Cheniere Energy Partners is a bargain or overpriced? Let’s dive into what really matters for value-focused investors like you. The stock has climbed 10.8% over the past year. However, recent weeks tell a slightly different story, with a 4.1% dip in the last seven days and a year-to-date loss of 6.3%. News around the liquid natural gas market, with shifting export volumes and global energy demand, has been driving much of the price action. There is also increased attention...

CommScope Holding Company (COMM) has returned to profitability over the past year, despite reported earnings growth averaging -1.6% annually for the last five years. Margins have moved from negative to positive, though the latest results include a notable $98.4 million one-off loss that impacted the bottom line. Revenue is projected to climb at 9.1% per year, a pace that trails the broader US market's 10.3% outlook. Shares currently trade at $16.84. See our full analysis for CommScope Holding...

Stepan (SCL) reported that earnings have declined 26.1% per year over the last five years, and its current net profit margin is 2%, slightly below last year's 2.1%. Revenue is forecast to rise 5.3% annually, which trails the broader US market growth rate of 10.3%. However, earnings are projected to surge 53.4% per year, far ahead of the US average forecast of 15.7%. With valuation multiples below both industry and peer averages, investors may see recent trends as a setup for potential upside...

United Therapeutics (UTHR) reported net profit margins of 40.7%, edging up from last year’s 40.3%. Over the past five years, earnings rose at a robust 22.8% annual rate, but most recent profit growth slowed to 14.5%. With analysts forecasting 10% annual earnings growth and revenue set to expand 9.4% per year, both metrics are tracking a bit below the wider US market outlook. Strong profitability, solid margins, and a Price-To-Earnings ratio of 16.1x, which is under both industry and peer...

Verra Mobility (VRRM) posted a one-off loss of $98.3 million for the twelve months ending September 30, 2025, resulting in net profit margins falling to 5.4% from 11.6% a year ago. Over the past five years, however, earnings have grown at an impressive 21.9% annual rate and are projected to accelerate by 35% per year moving forward, outpacing US market averages. While lower margins and a dip in reported earnings quality raise some near-term questions, a strong growth forecast and a share...

Golden Matrix Group (GMGI) is currently unprofitable, with losses having grown at an average annual rate of 66.5% over the last five years. Still, the company is forecasting revenue growth of 13% per year, outpacing the broader US market’s expected 10.3% growth, with earnings projected to climb 56.22% annually and potential profitability within three years. See our full analysis for Golden Matrix Group. Next, we will put these numbers head-to-head with the most widely discussed market...

EMCOR Group (EME) reported net profit margins of 7.1%, up from 6% the previous year, as the company continued delivering high quality earnings. Over the last five years, earnings grew at an impressive 36.9% annually. The most recent year's growth of 33.9% fell just short of this pace. While revenue and earnings are projected to grow at 8.8% and 10.5% per year respectively, both figures lag the broader US market forecasts. This could potentially cap near-term excitement for investors. Strong...

LKQ (LKQ) is forecast to grow earnings by 11.56% per year, with revenue expected to rise 2.8% annually, both trailing the broader US market growth rates. Despite profit margins slipping slightly to 5% from last year’s 5.1% and a 3.1% annual earnings decline over the last five years, the company continues to report high quality earnings. Current forecasts for profit and revenue growth set the stage for cautious optimism among investors heading into the next cycle. See our full analysis for...

Talkspace (TALK) has turned profitable, with earnings climbing at an annual rate of 29.1% over the last five years. Forecasts point to a 41.2% earnings growth each year ahead. Revenue is expected to rise 16.9% per year, outpacing the broader US market’s 10.3% growth. However, a one-off loss of $1.2 million weighed on the most recent results through September 30, 2025. Trading at $2.9, shares sit below an estimated fair value of $15.82. This has set the stage for ongoing debate about growth...

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com...

Kraft Heinz (KHC) remains unprofitable, with losses having increased at an average rate of 12.9% per year over the last five years. However, analysts project earnings to grow by 67.72% per year, with the company expected to turn profitable within the next three years. This pace outstrips the average market. Revenue is forecast to rise just 0.7% per year, trailing the US market’s 10.3%. The stock currently trades at $24.58, beneath the estimated fair value of $69.24, and its price-to-sales...

The U.S. market has recently experienced mostly positive momentum, with major indices like the Nasdaq and S&P 500 showing gains following strong earnings reports from big tech companies such as Amazon. In this environment of optimism, investors often look for high growth potential in tech stocks that demonstrate robust fundamentals and innovative capabilities to capitalize on emerging trends.

Haverty Furniture Companies (HVT) is set for a sharp turnaround as earnings are forecast to grow at an impressive 90.1% per year, far exceeding the expected 15.7% pace for the broader US market. Despite this robust outlook, net margins have slipped to 2.6%, down from 3.6% last year, and the company has posted annual earnings declines of 21.1% over the past five years. With a revenue growth projection of 6.9% per year that lags the national average, investors face a mixed set of signals as the...

Cactus (WHD) is projected to deliver 19.7% annual revenue growth and matching annual earnings growth, both trending above market averages. Even with a net profit margin of 15.9%, slightly down from last year's 16.6%, the company boasts a five-year average earnings growth rate of 33.3%, although earnings dipped in the most recent year. Investors will note steady long-term growth and a solid margin, with the only minor risk flagged being recent insider selling. See our full analysis for...

First Savings Financial Group (FSFG) posted standout results this period, with net profit margins surging to 27.1% compared to last year’s 12.7%. EPS growth over the past twelve months clocked in at a staggering 135.1%, a sharp turnaround from the company’s 5-year trend of a 28.3% annual earnings decline. Shares recently traded at $29.82, which is above the stock’s estimated fair value of $20, while its price-to-earnings ratio of 9.5x remains notably lower than peer and industry averages. For...

What are the early trends we should look for to identify a stock that could multiply in value over the long term...

Wolfspeed (WOLF) remains unprofitable, with net losses accelerating at a rate of 38.7% per year over the past five years. The company’s net profit margin has not improved in the last year, and there are no signals of profit growth picking up speed. Compared to the sector, the stock trades at a Price-to-Sales ratio of just 0.9x, sharply below the US semiconductor industry average. See our full analysis for Wolfspeed. Next, we'll see how the recent results compare with the broader narratives...

Transocean (NYSE:RIG) remains unprofitable, with net losses increasing at a rate of 28.3% per year over the past five years. While revenue is expected to decline at an annual rate of 1.3% over the next three years, earnings are forecast to rebound sharply with expectations of a 132% annual growth rate and a return to profitability within that period. Investors are weighing the company’s attractive valuation and strong anticipated earnings growth as Transocean works to reverse ongoing revenue...

It's easy to match the overall market return by buying an index fund. But if you buy individual stocks, you can do both...

When a single insider purchases stock, it is typically not a major deal. However, when multiple insiders purchase...

MiMedx Group (MDXG) posted annual earnings growth projections of 15.73% and revenue growth set at 6.7% per year, even as its net profit margin slipped to 10.4% from last year’s 23.2%. Despite a shortfall in earnings growth over the past year, the company has built a solid five-year track record with average annual earnings growth of 67.7% and high-quality current profits. Shares trade at $7.40, notably below the assessed fair value of $16.75. This presents a potential value opportunity, but...

Federal Signal (FSS) maintained a steady net profit margin of 11.2% year over year, underscoring consistent profitability. Over the last five years, the company’s earnings have grown at an average rate of 21.2% annually, but growth eased to 9.6% in the most recent year. Looking forward, analysts expect earnings to climb 11.8% per year and revenue to grow at 10.8% per year, outpacing the broader US market’s 10.3% forecast. With its current share price below DCF-based fair value and trading at...

Teladoc Health (TDOC) remains unprofitable, with forecasts indicating no expectation of profitability over the next three years. The company has narrowed its losses at a 12% annual rate over the past five years, while revenue is projected to increase by 2.3% per year. This revenue growth rate trails the US market average of 10.3%. Despite ongoing net losses and a stagnant profit margin, shares currently trade at a Price-to-Sales Ratio of 0.6x. This is well below both the US Healthcare...